6. Oral Contraceptives

Gissur J. Petursson; F. T. Fraunfelder; S. Martha Meyer

doi:10.1016/S0161-6420(81)35032-5

6. Oral Contraceptives

Gissur J. Petursson, F. T. Fraunfelder, S. Martha Meyer

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

Based on literature and data in the National Registry of Drug-Induced Ocular Side Effects, the current status of oral contraceptives and adverse ocular effects is presented. The possible relationship of this group of drugs to retinal vascular disorders, color vision, macular or retinal abnormalities, neuro-ophthalmic disorders, and contact lens wear is reviewed. An overview of current guidelines for the management of patients on oral contraceptives from the ophthalmic viewpoint is presented.

Original language	English (US)
Pages (from-to)	368-371
Number of pages	4
Journal	Ophthalmology
Volume	88
Issue number	4
DOIs	https://doi.org/10.1016/S0161-6420(81)35032-5
State	Published - 1981
Externally published	Yes

Keywords

colorvision
contact lens wear
estrogen
macular edema
neuro-ophthalmic disorders
ocular side effects
oral contraceptives
retinal vascular disorders
retinitis pigmentosa

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/S0161-6420(81)35032-5

Cite this

@article{3b38f899bf95414383f49f1877e6f402,

title = "6. Oral Contraceptives",

abstract = "Based on literature and data in the National Registry of Drug-Induced Ocular Side Effects, the current status of oral contraceptives and adverse ocular effects is presented. The possible relationship of this group of drugs to retinal vascular disorders, color vision, macular or retinal abnormalities, neuro-ophthalmic disorders, and contact lens wear is reviewed. An overview of current guidelines for the management of patients on oral contraceptives from the ophthalmic viewpoint is presented.",

keywords = "colorvision, contact lens wear, estrogen, macular edema, neuro-ophthalmic disorders, ocular side effects, oral contraceptives, retinal vascular disorders, retinitis pigmentosa",

author = "Petursson, {Gissur J.} and Fraunfelder, {F. T.} and Meyer, {S. Martha}",

note = "Funding Information: Supported in part by funds from Research to Prevent Blindness, Inc.",

year = "1981",

doi = "10.1016/S0161-6420(81)35032-5",

language = "English (US)",

volume = "88",

pages = "368--371",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - 6. Oral Contraceptives

AU - Petursson, Gissur J.

AU - Fraunfelder, F. T.

AU - Meyer, S. Martha

N1 - Funding Information: Supported in part by funds from Research to Prevent Blindness, Inc.

PY - 1981

Y1 - 1981

N2 - Based on literature and data in the National Registry of Drug-Induced Ocular Side Effects, the current status of oral contraceptives and adverse ocular effects is presented. The possible relationship of this group of drugs to retinal vascular disorders, color vision, macular or retinal abnormalities, neuro-ophthalmic disorders, and contact lens wear is reviewed. An overview of current guidelines for the management of patients on oral contraceptives from the ophthalmic viewpoint is presented.

AB - Based on literature and data in the National Registry of Drug-Induced Ocular Side Effects, the current status of oral contraceptives and adverse ocular effects is presented. The possible relationship of this group of drugs to retinal vascular disorders, color vision, macular or retinal abnormalities, neuro-ophthalmic disorders, and contact lens wear is reviewed. An overview of current guidelines for the management of patients on oral contraceptives from the ophthalmic viewpoint is presented.

KW - colorvision

KW - contact lens wear

KW - estrogen

KW - macular edema

KW - neuro-ophthalmic disorders

KW - ocular side effects

KW - oral contraceptives

KW - retinal vascular disorders

KW - retinitis pigmentosa

UR - http://www.scopus.com/inward/record.url?scp=0019559698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019559698&partnerID=8YFLogxK

U2 - 10.1016/S0161-6420(81)35032-5

DO - 10.1016/S0161-6420(81)35032-5

M3 - Article

C2 - 6973118

AN - SCOPUS:0019559698

SN - 0161-6420

VL - 88

SP - 368

EP - 371

JO - Ophthalmology

JF - Ophthalmology

IS - 4

ER -

6. Oral Contraceptives

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this